BIOMAT Database Logo BIOMAT Database Logo

A correlation between severe haemolytic disease of the fetus and newborn and maternal ABO blood group. 2014

B Doyle, and J Quigley, and M Lambert, and J Crumlish, and C Walsh, and P McParland, and M Culliton, and K Murphy, and J Fitzgerald
Red Cell Immunohaematology Laboratory, Irish Blood Transfusion Service, Dublin, Ireland.

OBJECTIVE To analyse anti-D quantification levels and frequency of intrauterine transfusion (IUT), per maternal ABO blood group. BACKGROUND Maternally derived red cell allo-antibodies can target fetal red cell antigens in utero leading to haemolytic disease and fetal anaemia. When a clinically significant allo-antibody is formed the priority is ascertaining the risk to the fetus and maternal ABO blood groups are not considered relevant. METHODS This was a 10-year retrospective, observational study carried out on women referred for anti-D quantification (n = 1106), and women whose fetuses required an IUT to treat fetal anaemia (n = 62) due to anti-D, in the Republic of Ireland. RESULTS Relative to the overall incidence of RhD allo-immunisation by blood group, women of blood group A were more likely to require IUT compared with those who were blood group O (P = 0.002). CONCLUSIONS It is known that ABO feto-maternal compatibility can influence the incidence and level of red cell allo-antibodies in pregnancy; however, it does not account for the significantly high rate of severe haemolytic disease requiring IUT seen in blood group A women.

UI MeSH Term Description Entries
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D001805 Blood Transfusion, Intrauterine In utero transfusion of BLOOD into the FETUS for the treatment of FETAL DISEASES, such as fetal erythroblastosis (ERYTHROBLASTOSIS, FETAL). Fetal Transfusion,Intrauterine Transfusion,Blood Transfusions, Intrauterine,Fetal Transfusions,Intrauterine Blood Transfusion,Intrauterine Blood Transfusions,Intrauterine Transfusions,Transfusion, Fetal,Transfusion, Intrauterine,Transfusion, Intrauterine Blood,Transfusions, Fetal,Transfusions, Intrauterine,Transfusions, Intrauterine Blood
D004899 Erythroblastosis, Fetal A condition characterized by the abnormal presence of ERYTHROBLASTS in the circulation of the FETUS or NEWBORNS. It is a disorder due to BLOOD GROUP INCOMPATIBILITY, such as the maternal alloimmunization by fetal antigen RH FACTORS leading to HEMOLYSIS of ERYTHROCYTES, hemolytic anemia (ANEMIA, HEMOLYTIC), general edema (HYDROPS FETALIS), and SEVERE JAUNDICE IN NEWBORN. Hemolytic Disease of Newborn,Erythroblastosis Fetalis,Erythroblastoses, Fetal,Erythroblastosis Fetali,Fetal Erythroblastoses,Fetal Erythroblastosis,Fetali, Erythroblastosis,Fetalis, Erythroblastosis,Newborn Hemolytic Disease,Newborn Hemolytic Diseases
D005260 Female Females
D005331 Fetomaternal Transfusion Transplacental passage of fetal blood into the circulation of the maternal organism. (Dorland, 27th ed) Hemorrhage, Fetomaternal,Fetomaternal Hemorrhage,Fetomaternal Hemorrhages,Fetomaternal Transfusions,Hemorrhages, Fetomaternal,Transfusion, Fetomaternal,Transfusions, Fetomaternal
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000017 ABO Blood-Group System The major human blood type system which depends on the presence or absence of two antigens A and B. Type O occurs when neither A nor B is present and AB when both are present. A and B are genetic factors that determine the presence of enzymes for the synthesis of certain glycoproteins mainly in the red cell membrane. ABH Blood Group,ABO Blood Group,ABO Factors,Blood Group H Type 1 Antigen,H Blood Group,H Blood Group System,ABO Blood Group System,Blood Group, ABH,Blood Group, ABO,Blood Group, H,Blood-Group System, ABO,Factors, ABO,System, ABO Blood-Group
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective

Related Publications

B Doyle, and J Quigley, and M Lambert, and J Crumlish, and C Walsh, and P McParland, and M Culliton, and K Murphy, and J Fitzgerald
Blood group distribution and ABO haemolytic disease of the newborn in Jamaica.
June 1980, Medical laboratory sciences,
B Doyle, and J Quigley, and M Lambert, and J Crumlish, and C Walsh, and P McParland, and M Culliton, and K Murphy, and J Fitzgerald
ABO haemolytic disease of the fetus and newborn in a blood group AB neonate due to maternal immunoglobulin G anti-A and anti-B antibodies.
February 2021, British journal of haematology,
B Doyle, and J Quigley, and M Lambert, and J Crumlish, and C Walsh, and P McParland, and M Culliton, and K Murphy, and J Fitzgerald
Severe ABO hemolytic disease of fetus and newborn requiring blood exchange transfusion.
January 2018, Asian journal of transfusion science,
B Doyle, and J Quigley, and M Lambert, and J Crumlish, and C Walsh, and P McParland, and M Culliton, and K Murphy, and J Fitzgerald
The spectrum of ABO haemolytic disease of the fetus and newborn in neonates born to group O mothers.
September 2022, Vox sanguinis,
B Doyle, and J Quigley, and M Lambert, and J Crumlish, and C Walsh, and P McParland, and M Culliton, and K Murphy, and J Fitzgerald
Serum blood group substances and ABO haemolytic disease.
January 1969, British journal of haematology,
B Doyle, and J Quigley, and M Lambert, and J Crumlish, and C Walsh, and P McParland, and M Culliton, and K Murphy, and J Fitzgerald
ABO haemolytic disease of the newborn.
March 1977, Nursing mirror and midwives journal,
B Doyle, and J Quigley, and M Lambert, and J Crumlish, and C Walsh, and P McParland, and M Culliton, and K Murphy, and J Fitzgerald
Haemolytic disease of fetus and newborn caused by ABO antibodies in a cisAB offspring.
October 2008, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis,
B Doyle, and J Quigley, and M Lambert, and J Crumlish, and C Walsh, and P McParland, and M Culliton, and K Murphy, and J Fitzgerald
Haemolytic disease of the fetus and newborn.
August 2015, Vox sanguinis,
B Doyle, and J Quigley, and M Lambert, and J Crumlish, and C Walsh, and P McParland, and M Culliton, and K Murphy, and J Fitzgerald
Maternal antibodies against fetal blood group antigens A or B: lytic activity of IgG subclasses in monocyte-driven cytotoxicity and correlation with ABO haemolytic disease of the newborn.
December 1988, British journal of haematology,
B Doyle, and J Quigley, and M Lambert, and J Crumlish, and C Walsh, and P McParland, and M Culliton, and K Murphy, and J Fitzgerald
ABO incompatibility and haemolytic disease of the newborn.
June 1958, Archives of disease in childhood,
Copied contents to your clipboard!